{
  "id": 2563962,
  "title": "New Treatment Offers Hope to People With Serious Heart Problems",
  "url": "https://urgent.news/2026/08/22/new-treatment-offers-hope-to-people-with-serious-heart-problems",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-22T11:18:14.000Z",
  "source": {
    "name": "ProPakistani",
    "slug": "propakistani",
    "url": "https://propakistani.pk/2026/08/22/new-treatment-offers-hope-to-people-with-serious-heart-problems/"
  },
  "original_language": "en",
  "account": "A novel stem cell therapy has demonstrated promising outcomes in an early clinical trial conducted in China, significantly enhancing heart function in nine out of ten patients with severe heart failure. Researchers at Nanjing Drum Tower Hospital administered the treatment to 10 patients by utilizing cells derived from their own bodies, which were initially converted into induced pluripotent stem cells (iPSCs). These iPSCs were subsequently transformed into heart muscle cells and injected into damaged regions of the patients’ hearts to facilitate tissue repair, stimulate new heart muscle growth, and enhance overall heart function.\n\nA control group of 10 patients who underwent coronary artery bypass surgery served as a comparison. Participants were closely monitored through cardiac imaging, laboratory tests, and heart function assessments for 12 months. After this period, nine patients who received the stem cell treatment exhibited substantial improvement in heart function compared to the control group. This improvement led to mild symptoms during normal daily activities. Researchers also noted notable reductions in chest tightness and shortness of breath, along with better performance in a six-minute walking test, where patients showed nearly double the improvement observed in the control group.\n\nAdditionally, the therapy resulted in an increased amount of blood pumped by the heart with each beat. However, only 60% of patients in the control group achieved a similar level of improvement. Importantly, the stem cell treatment was associated with no severe adverse events; two patients experienced clinically significant rapid heartbeats, which peaked around two to three weeks post-procedure and subsequently resolved. The study also suggested that the therapy could potentially slow the age-related deterioration of heart muscle, a common issue in heart failure patients who experience symptoms such as shortness of breath, fatigue, leg swelling, rapid weight gain, and persistent coughing.\n\nWhile the findings are encouraging, researchers stressed that the study involved a limited number of patients and is still at an early stage. Further studies with a larger patient population and longer follow-up periods are required to fully assess the risks and benefits of this iPSC-based heart muscle therapy before it can be considered a proven or widely available treatment. As noted, heart transplantation remains an effective option for severe cases but is limited by the scarcity of donor hearts, making the stem cell therapy a potentially valuable alternative.",
  "summary": "A new stem cell therapy has shown promising results in China, improving heart function in nine out of 10 patients … Read More The post New Treatment Offers Hope to People With Serious Heart Problems appeared first on ProPakistani .",
  "key_points": [
    "Stem cell therapy improved heart function in 90% of patients with severe heart failure.",
    "Treatment involved iPSCs derived from patients' own cells, injected into damaged heart tissue.",
    "No severe adverse events reported; therapy may slow heart muscle deterioration."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}